SMS Lifesciences Share Price Today | Stock Price & SMS Lifesciences Share Screener
As of November 24, 2025, the live SMS Lifesciences share price (NSE: SMSLIFE) is ₹1,353.50 on NSE and ₹1,348.75 on BSE, down 5.87% from the previous close, with shares trading between ₹1,333.10 and ₹1,447.10 in today's trading session, and a 52-week range of ₹1,119.60–₹1,437.90. Check SMSLIFE yearly price range for the annual price range and momentum. Use the SMS Lifesciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today SMS Lifesciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹92 and net income of ₹4, with EBITDA of ₹10, an operating margin of 8.0% and a profit margin of 4.4%.
SMS Lifesciences Share Price Chart
Track the current stock price of SMS Lifesciences with an interactive chart. Analyse SMSLIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete SMS Lifesciences stock quote in one place.
The quote of ₹1,353.50 sits between the 52-week low of ₹1,119.60 and the 52-week high of ₹1,437.90, and the latest session moved -5.87% from the previous close.
SMS Lifesciences Company Profile - Fundamental Screener
Screen SMS Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SMSLIFE shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE320X01016.
Company Details
Classification
Identifiers and Leadership
SMS Lifesciences Balance Sheet Screener
Screen SMSLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹390 against total liabilities of ₹390, down from ₹391 in 2024.
Latest statistics put total assets at ₹390 and shareholder funds at ₹212, with a leverage ratio of 0.50.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Assets | 151 | 156 | 159 | 156 | 126 | 107 | 142 |
| Fixed Assets | 232 | 223 | 228 | 142 | 130 | 124 | 119 |
Liabilities |
|||||||
| Total Liabilities | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Liabilities | 36 | 52 | 73 | 56 | 59 | 50 | 39 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 212 | 194 | 188 | 165 | 129 | 116 | 106 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 194 | 174 | 166 | 149 | 126 | 113 | 103 |
SMS Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen SMS Lifesciences income statement and profit fundamentals. Analyze SMSLIFE quarterly results. SMS Lifesciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2025-Mar, revenue was ₹92 and net profit was ₹4, equal to earnings per unit of ₹9.83, at an operating margin of 8%.
In that period expenses were ₹82, interest cost ₹2 and tax ₹1. The next period listed, 2025-Jun, shows revenue of ₹84 and net profit of ₹4.
| Item | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 92 | 84 | 92 | 93 | 81 | 85 | 69 | 75 | 70 | 73 | 102 | 83 | 81 | 89 | 84 |
| Expenses | 82 | 71 | 79 | 76 | 70 | 72 | 62 | 72 | 61 | 63 | 89 | 74 | 73 | 79 | 74 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 10 | 13 | 14 | 17 | 11 | 13 | 7 | 3 | 8 | 10 | 13 | 9 | 8 | 10 | 10 |
| Operating Profit % | 8.00% | 14.00% | 13.00% | 18.00% | 11.00% | 15.00% | 4.00% | 3.00% | 11.00% | 13.00% | 7.00% | 10.00% | 10.00% | 11.00% | 10.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 4 | 7 | 7 | 11 | 5 | 7 | 2 | -3 | 2 | 4 | 9 | 5 | 4 | 6 | 7 |
| Tax | 1 | 3 | 1 | 4 | 1 | 2 | 0 | 1 | 2 | 0 | 1 | 2 | 1 | 2 | 2 |
| Net Profit | 4 | 4 | 7 | 7 | 3 | 5 | 2 | -4 | 0 | 4 | 8 | 2 | 3 | 4 | 5 |
| EPS | 9.83 | 13.75 | 19.53 | 23.15 | 15.46 | 18.08 | 5.66 | -5.94 | 2.20 | 14.24 | 26.00 | 9.95 | 9.10 | 13.18 | 16.72 |
SMS Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen SMSLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹34.
Over the same period, investing activities used ₹15 and financing activities used ₹19.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||
| Operating Activities | 34 | 24 | 15 | -11 | 35 | 15 | 30 |
| Investing Activities | -15 | -19 | -31 | -7 | -26 | -27 | -44 |
Financing and Net Cash | |||||||
| Financing Activities | -19 | -7 | 17 | 11 | -3 | 12 | 15 |
| Net Cash Flow | 0 | -1 | 0 | -8 | 6 | 0 | 1 |
SMS Lifesciences Shareholding Pattern Screener
See SMS Lifesciences shareholding pattern with promoter, FII, and DII holdings. Check SMS Lifesciences promoter holding and ownership changes for SMSLIFE on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 71.41%, foreign institutions 0.00%, domestic institutions 0.00% and the public 25.55%, spread across 7,479 shareholders.
The shareholder count was 7,479 in 2025-Mar, compared with 7,412 in 2025-Jun.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 71.41% | 71.41% | 71.41% | 71.19% | 71.41% | 71.41% | 71.41% | 70.32% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.03% | 0.00% | 0.00% | 0.01% | 0.02% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.55% | 25.55% | 25.32% | 25.64% | 25.56% | 25.56% | 25.51% | 25.98% |
| Other Holding | 3.04% | 3.01% | 3.25% | 3.17% | 3.02% | 3.01% | 3.08% | 3.69% |
| Shareholder Count | 7,479 | 7,412 | 7,521 | 8,116 | 7,861 | 7,849 | 7,626 | 8,349 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by SMS Lifesciences. SMS Lifesciences dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹1.50 per unit for 2025-March, a yield of 0.13%, compared with ₹1.50 for 2024-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹1.50, ₹1.50 and ₹1.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.50 | 0.13% |
| 2024-March | ₹1.50 | 0.14% |
| 2023-March | ₹1.50 | 0.22% |
| 2022-March | ₹1.50 | 0.29% |
| 2021-March | ₹1.50 | 0.21% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 0.84% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
SMS Lifesciences Stock Index Membership - Nifty & Sensex
See which indices include SMS Lifesciences stock. Check SMSLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
SMS Lifesciences Market Events Screener - Corporate Actions
Get SMS Lifesciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check SMS Lifesciences stock events that may affect SMSLIFE share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Annual General Meeting dated .
It is followed by Dividend dated and Dividend dated .
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.81% | ||
| Dividend | ₹ 1.50 /share | 16.44% | ||
| Dividend | ₹ 1.50 /share | 8.83% | ||
| Dividend | ₹ 1.50 /share | -8.24% | ||
| Dividend | ₹ 1.50 /share | 130.55% | ||
| Annual General Meeting | NA | 55.04% | ||
| Dividend | ₹ 1.50 /share | -10.95% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.64% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -6.75% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 4.87% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -6.46% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -10.06% |
| 2016-06-22 | 2016-06-22 | Change Of Name | NA | - |
SMS Lifesciences Competitors Screener - Peer Stocks Comparison
Screen SMSLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 405,824 | 38.74 | 54,729 | 9.71% | 10,980 | 57.82 |
| Divis Laboratories | 176,709 | 71.11 | 9,712 | 18.67% | 2,191 | 59.81 |
| Cipla | 121,624 | 22.36 | 28,410 | 7.12% | 5,291 | 42.33 |
| Torrent Pharmaceuticals | 121,164 | 60.51 | 11,539 | 6.99% | 1,911 | 70.23 |
| Dr Reddys Laboratories | 100,604 | 17.53 | 33,741 | 16.73% | 5,725 | 35.45 |
| Zydus Life Science | 94,999 | 18.88 | 23,511 | 18.55% | 4,615 | 35.94 |
| Mankind Pharma | 93,358 | 52.66 | 12,744 | 20.90% | 2,007 | 23.38 |
| Lupin | 90,063 | 20.71 | 22,910 | 13.74% | 3,306 | 56.75 |
| Alkem Laboratories | 67,775 | 29.08 | 13,458 | 3.70% | 2,216 | 64.68 |
| Aurobindo Pharma | 65,271 | 19.24 | 32,346 | 9.43% | 3,484 | 61.48 |
SMS Lifesciences Company Announcements - News & Reports Screener
Screen SMSLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated November 23, 2025 and November 21, 2025.
| Date | Update | Actions |
|---|---|---|
| Board Meeting Outcome for For The Meeting Held On November 10 2025 | - | |
| 2025-11-23 | Temporary Withholding Of Dividend | - |
| 2025-11-21 | Report (Special Window) | - |
| 2025-11-20 | Board Meeting Intimation for 95Th Board Meeting (10.11.2025) | - |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-10-12 | Report (Special Window) | - |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-09-29 | Update (Material Subsidiary) | - |
| 2025-09-26 | ANVISA Inspection | - |
| 2025-09-20 | Closure of Trading Window | - |
| 2025-09-15 | Report (Special Window) | - |
| 2025-09-09 | Annual Report (Weblink) | - |
| 2025-09-06 | Newspaper Advertisement (AGM Notice) | - |
| 2025-09-06 | Reg. 34 (1) Annual Report. | - |
| 2025-09-06 | AGM Notice (Sept 30 2025) | - |
| 2025-08-28 | Record Date (Dividend) | - |
| 2025-08-26 | Events Calendar (AGM) | - |
| 2025-08-21 | Announcement under Regulation 30 (LODR)-Change of Company Name | - |
| 2025-08-12 | Newspaper Publication (Financial Results) | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,353.50, within a 52-week range of ₹1,119.60 to ₹1,437.90. The P/E ratio is 22.27 and the P/B ratio is 1.82, with earnings per unit of ₹66.51. Market capitalisation stands at ₹354.00 Cr and the dividend yield is 0.13%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 26, 2025. This page covers 7 balance sheet periods, 15 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.